Aptose Announces Closing Of $3 Million Investment By Hanmi Pharmaceutical
Amount Raised
$3 Million
Round Type
Seed
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearchDescription
Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, today announced closing of a $3 million investment in common shares of the Company (the “Shares”) as the first tranche of a private equity investment for up to a maximum of $7 million or 19.99 percent ownership interest by Hanmi Pharmaceutical, Inc. (“Hanmi”), Seoul, South Korea. Under the terms of the strategic investment, Hanmi purchased each Share at a price of $4.488, representing a premium over Aptose’s common stock price.
Quick answer
Aptose Biosciences raised $3 Million in a Seed round, dated September 6, 2023. Aptose Biosciences is based in San Diego, California, United States.
- How much did Aptose Biosciences raise?
- Aptose Biosciences raised $3 Million in a Seed round on September 6, 2023.
- What does Aptose Biosciences do?
- Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.
- Where is Aptose Biosciences based and how big is it?
- Aptose Biosciences is based in San Diego, California, United States. Fundz records about 35 employees.
- Who are the decision-makers at Aptose Biosciences?
- Fundz holds 1 contact at Aptose Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Aptose Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Actym Therapeutics raised $60M (Series A) on October 18, 2023.
- Qihan Biotech raised an undisclosed amount (Series B) on September 23, 2023.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Actimed Therapeutics raised $6.1M (Series A) on August 22, 2023.
- Ikena Oncology raised $43M on August 4, 2023.
- Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.
Who to call at Aptose Biosciences, and when
A new round usually means Aptose Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aptose Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aptose Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aptose Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aptose Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aptose Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.